Feldman, A M <br/><br/>
Response to "clarification of enrolled subjects in tolvaptan HF trials".  [electronic resource] 

 -  Clinical pharmacology and therapeutics  Dec 2014 
 - 661 p.  digital 
<br/><br/> Publication Type: Letter; Comment 
<br/><br/><label>ISSN: </label>1532-6535 
<br/><br/><label>Standard No.: </label>10.1038/clpt.2014.191  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antidiuretic Hormone Receptor Antagonists<br/>Arginine Vasopressin--antagonists & inhibitors<br/>Drug Design<br/>Heart Failure--drug therapy<br/>Humans